AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
AtriCure (ATRC) Misses Q4 EPS by 14c, Revenues Miss; Offers 1Q & FY21 EPS/Revenue Guidance Below Consensus
February 23, 2021 4:07 PM ESTAtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.42), $0.14 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $57.7 million versus the consensus estimate of $58.1 million.
Despite challenges posed in 2020 as a result of the pandemic, we made meaningful progress across our business with our strategic initiatives, said Michael Carrel, President and Chief Executive Officer... More
